Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate is effective for treating rheumatoid arthritis but requires regular monitoring.

Men with male pattern baldness may not have different hormone levels, but their hair follicles are likely more sensitive to hormones.

Chemicals and stem cells combined have advanced regenerative medicine with few safety concerns, focusing on improving techniques and treatment effectiveness.

Exposure to certain sex hormones can increase health risks, while some hormone therapies may offer benefits for specific conditions.

Keratin hydrogels from human hair show promise for tissue engineering and regenerative medicine.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Methotrexate dose has little effect on its toxicity when used with adalimumab for early rheumatoid arthritis.

Hair follicles can be used to quickly assess drug effects in cancer treatment.

Low-level light therapy is FDA-approved for male pattern hair loss, increases hair count and strength, and is considered safe for use.

Treating chronic hand eczema costs about the same in statutory and occupational health insurances in Germany, but work-related cases may lead to higher indirect costs due to longer work absences.

Cataract surgery guidelines vary across Europe, and generic finasteride sales for hair loss have grown due to pill splitting.

Cataract surgery in Europe varies in frequency and cost between countries.

Real-life dosing of biologics for plaque psoriasis often deviates from recommended guidelines, especially for high-need patients.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

New cancer treatments are more precise and less toxic, improving survival rates, but Asia faces challenges in adopting these advancements.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Dutasteride is highly effective for hair loss treatment in Korea, with more side effects than finasteride.

Baricitinib treatment helps regrow eyebrow, eyelash, and scalp hair in severe alopecia areata, improving patients' emotional well-being and quality of life.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Notch1 signaling is impaired in hidradenitis suppurativa, affecting skin and hair cells.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Hair transplantation can effectively restore hair in patients with stable lichen planopilaris or frontal fibrosing alopecia.

People with alopecia areata have a higher risk of depression and anxiety, and often face unemployment and work absences.

Vitiligo patients should be routinely screened for thyroid disease and, if extensive or prolonged, also for RA, PA, and type 2 diabetes.

The Brigham Eyelash Tool for Alopecia (BELA) is a reliable way to measure eyelash loss in alopecia areata patients.

5-Alpha-Reductase inhibitors shorten COVID-19 recovery time in men.